HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yuka Sasaki Selected Research

Nausea

3/2023Effect of Mirtazapine for the Prevention of Nausea and Vomiting in Patients With Thoracic Cancer Receiving Platinum-based Chemotherapy.
4/2022Efficacy of cisplatin plus vinorelbine adjuvant chemotherapy with split-dose administration of cisplatin after complete resection of stage II-IIIA non-small cell lung cancer.
1/2017Efficacy of Single-dose First-generation 5-HT3 Receptor Antagonist and Dexamethasone for Preventing Nausea and Vomiting Induced by Low-dose Carboplatin-based Chemotherapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yuka Sasaki Research Topics

Disease

25Neoplasms (Cancer)
01/2024 - 05/2005
21Tuberculosis (Tuberculoses)
10/2020 - 08/2002
11Infections
08/2023 - 07/2004
10Pulmonary Tuberculosis
10/2020 - 12/2003
7Carcinogenesis
03/2021 - 05/2005
5Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2022 - 11/2016
5Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis)
07/2019 - 08/2003
4Disease Progression
01/2020 - 07/2008
3Nausea
03/2023 - 01/2017
3Pulmonary Aspergillosis
01/2023 - 03/2022
3Lung Neoplasms (Lung Cancer)
05/2022 - 01/2019
3Lung Diseases (Lung Disease)
01/2020 - 11/2016
2Pancreatic Neoplasms (Pancreatic Cancer)
01/2024 - 05/2022
2Fever (Fevers)
08/2023 - 01/2019
2Vomiting
03/2023 - 01/2017
2Asthma (Bronchial Asthma)
01/2023 - 06/2003
2Aspergillosis
01/2023 - 02/2022
2Body Weight (Weight, Body)
10/2022 - 05/2004
2Anorexia
04/2022 - 01/2012
2Melanoma (Melanoma, Malignant)
03/2022 - 02/2018
2Pain (Aches)
10/2021 - 11/2015
2Pleurisy (Pleuritis)
09/2019 - 07/2008
2Interstitial Lung Diseases (Interstitial Lung Disease)
05/2018 - 02/2018
2Alzheimer Disease (Alzheimer's Disease)
05/2017 - 08/2012
2Colorectal Neoplasms (Colorectal Cancer)
09/2015 - 01/2012
2Carcinoma (Carcinomatosis)
01/2014 - 05/2004
2Type 1 Diabetes Mellitus (Autoimmune Diabetes)
08/2004 - 06/2003
1Osteoblastoma
03/2024
1Hypoxia (Hypoxemia)
02/2024
1Body Dysmorphic Disorders (Body Dysmorphic Disorder)
12/2023
1Mental Disorders (Mental Disorder)
12/2023
1Septic Shock (Toxic Shock Syndrome)
12/2023
1Diarrhea
12/2023
1Hypothermia
12/2023
1Hyperplasia
11/2023
1Cortical Blindness (Anton Syndrome)
09/2023
1Stroke (Strokes)
09/2023
1Pancytopenia
08/2023
1Sarcoidosis (Schaumann Disease)
08/2023
1Sleepiness
03/2023
1Hypertension (High Blood Pressure)
01/2023
1Hemoptysis
01/2023
1Hyperuricemia
01/2023

Drug/Important Bio-Agent (IBA)

5EnzymesIBA
01/2023 - 05/2008
5DNA (Deoxyribonucleic Acid)IBA
02/2022 - 05/2005
5Prostaglandin-E SynthasesIBA
03/2021 - 12/2009
4MacrolidesIBA
08/2023 - 11/2016
4Biomarkers (Surrogate Marker)IBA
03/2022 - 01/2019
4Monoclonal AntibodiesIBA
08/2021 - 05/2005
4prostacyclin synthetase (prostacyclin synthase)IBA
01/2021 - 11/2015
3Poly(ADP-ribose) Polymerase InhibitorsIBA
01/2024 - 03/2022
3Immunoglobulin G (IgG)IBA
01/2023 - 03/2006
3Cisplatin (Platino)FDA LinkGeneric
04/2022 - 01/2019
3AntigensIBA
07/2021 - 07/2004
3Dinoprostone (PGE2)FDA Link
03/2021 - 12/2009
3VaccinesIBA
01/2020 - 03/2006
3AntibodiesIBA
01/2020 - 01/2018
3Rifampin (Rifampicin)FDA LinkGeneric
05/2017 - 07/2008
3GoldIBA
01/2016 - 05/2008
3InterferonsIBA
01/2014 - 08/2004
3Isoniazid (Ftivazide)FDA LinkGeneric
09/2011 - 05/2008
3AcidsIBA
07/2008 - 08/2002
2olaparibIBA
01/2024 - 05/2022
2LipopolysaccharidesIBA
12/2023 - 11/2015
2AntiemeticsIBA
03/2023 - 01/2017
2Small Interfering RNA (siRNA)IBA
05/2022 - 01/2019
2Proteins (Proteins, Gene)FDA Link
10/2021 - 01/2014
2ProstaglandinsIBA
03/2021 - 09/2015
2Therapeutic UsesIBA
04/2020 - 05/2018
2Immunoglobulin A (IgA)IBA
01/2020 - 09/2019
2Immunoglobulins (Immunoglobulin)IBA
01/2018 - 03/2006
2Cyclooxygenase 2 (Cyclooxygenase-2)IBA
11/2015 - 09/2015
2Tuberculin (PPD)IBA
09/2010 - 07/2004
2PyrazinamideFDA LinkGeneric
07/2008 - 08/2003
2SteroidsIBA
07/2008 - 11/2006
17,7'- dimethoxy- (4,4'- bi- 1,3- benzodioxole)- 5,5'- dicarboxylic acid dimethyl ester (BDD)IBA
12/2023
1Indomethacin (Indometacin)FDA LinkGeneric
12/2023
1Ligases (Synthetase)IBA
12/2023
1Acyl Coenzyme A (Acyl CoA)IBA
12/2023
1Cyclooxygenase InhibitorsIBA
12/2023
1ErbB Receptors (EGF Receptor)IBA
11/2023
1Epithelial Cell Adhesion MoleculeIBA
11/2023
1Erlotinib Hydrochloride (CP 358,774)FDA Link
11/2023
1Transforming Growth Factors (Transforming Growth Factor)IBA
11/2023
116S Ribosomal RNAIBA
08/2023
1AminoglycosidesIBA
08/2023
1PlatinumIBA
03/2023
1Histamine H1 Receptors (Histamine H1 Receptor)IBA
03/2023
1Serotonin (5 Hydroxytryptamine)IBA
03/2023
1Mirtazapine (Rexer)FDA LinkGeneric
03/2023

Therapy/Procedure

14Therapeutics
09/2023 - 07/2008
9Drug Therapy (Chemotherapy)
03/2023 - 07/2005
2Radiotherapy
07/2021 - 01/2011
2Duration of Therapy
01/2020 - 08/2003
2Chemoprevention
09/2015 - 10/2005
2Retreatment
12/2009 - 12/2003
2Gastrectomy
05/2006 - 05/2004
1Mandibular Osteotomy
03/2024
1Activities of Daily Living (ADL)
02/2024
1Intraperitoneal Injections
12/2023